These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6452055)

  • 21. Effect of thymic humoral factor on cellular immune factors of normal children and of pediatric patients with ataxia telangiectasia and Down's syndrome.
    Handzel ZT; Dolfin Z; Levin S; Altman Y; Hahn T; Trainin N; Gadot N
    Pediatr Res; 1979 Jul; 13(7):803-6. PubMed ID: 158166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome.
    Cossarizza A; Monti D; Bersani F; Scarfi MR; Zanotti M; Cadossi R; Franceschi C
    Aging (Milano); 1991 Sep; 3(3):241-6. PubMed ID: 1837237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the influence of age on immunity in Down's syndrome.
    Seger R; Buchinger G; Ströder J
    Eur J Pediatr; 1977 Jan; 124(2):77-87. PubMed ID: 137810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation.
    Stabile A; Pesaresi MA; Stabile AM; Pastore M; Sopo SM; Ricci R; Celestini E; Segni G
    Clin Immunol Immunopathol; 1991 Feb; 58(2):207-16. PubMed ID: 1824686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic characteristics of Down's syndrome.
    Gershwin ME; Crinella FM; Castles JJ; Trent JK
    J Ment Defic Res; 1977 Dec; 21(4):237-49. PubMed ID: 146742
    [No Abstract]   [Full Text] [Related]  

  • 26. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular immunity tests in children with Down's syndrome].
    Szigeti R; Révész T; Schuler D
    Orv Hetil; 1974 Sep; 115(38):2173-5. PubMed ID: 4277782
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal fetal immunological development in Down's syndrome.
    Thilaganathan B; Tsakonas D; Nicolaides K
    Br J Obstet Gynaecol; 1993 Jan; 100(1):60-2. PubMed ID: 8427840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Down's syndrome. Precocious aging of the immune system].
    Bonetti F; Licastro F; Chiricolo M; Franceschi C
    Recenti Prog Med; 1980 Dec; 69(6):679-709. PubMed ID: 6454228
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters.
    Licastro F; Chiricolo M; Mocchegiani E; Fabris N; Zannoti M; Beltrandi E; Mancini R; Parente R; Arena G; Masi M
    J Intellect Disabil Res; 1994 Apr; 38 ( Pt 2)():149-62. PubMed ID: 8193451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose- and time-response curves and relation to cellular immunity.
    Rigas DA; Elsasser P; Hecht F
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):587-608. PubMed ID: 4250088
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes.
    Lohrmann HP; Novikovs L; Graw RG
    J Exp Med; 1974 Jun; 139(6):1553-67. PubMed ID: 4598019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals.
    Naeim F; Walford RL
    J Gerontol; 1980 Sep; 35(5):650-5. PubMed ID: 6448891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
    Horwitz DA; Garrett MA
    J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological and virological investigations in Down's syndrome.
    Fekete G; Kulcsár G; Dán P; Nász I; Schuler D; Dobos M
    Eur J Pediatr; 1982 Feb; 138(1):59-62. PubMed ID: 6281021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
    Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
    Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal thymic differentiation in Down's syndrome.
    Cossarizza A; Monti D; Montagnani G; Forabosco A; Dagna-Bricarelli F; Franceschi C
    Thymus; 1989; 14(1-3):163-70. PubMed ID: 2533759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.
    Lockitch G; Singh VK; Puterman ML; Godolphin WJ; Sheps S; Tingle AJ; Wong F; Quigley G
    Pediatr Res; 1987 Nov; 22(5):536-40. PubMed ID: 2960948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.
    Barrena MJ; Echaniz P; Garcia-Serrano C; Zubillaga P; Cuadrado E
    Clin Exp Immunol; 1992 Apr; 88(1):41-4. PubMed ID: 1348667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.